Should Weakness in Centene Corporation’s (NYSE:CNC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Centene (NYSE:CNC) has had a rough three months with its share price down 15%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. In this article, … Read more

Centene (CNC) Expands Medicare Advantage Offerings in 36 States

Centene Corporation CNC unveiled the broadening of its Medicare Advantage offerings for next year. The leading health insurance company will provide a wide array of Medicare Advantage plans in 1,575 counties across 36 states during the 2022 Medicare Annual Enrollment Period (AEP). With people still bearing the brunt of the COVID-19 pandemic, the leading health … Read more

Hedge Funds Are Cashing Out Of Centene Corporation (CNC)

As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided to stick with hedge funds after a rough 2018 recouped their losses by the end of the fourth quarter of 2019. A significant number of hedge funds continued their strong … Read more

Centene CNC Investment Analysis

September 28, 2021, 13:45 pm ET, BY Thomas H. Kee Jr – Editor, Stock Traders Daily | Editor: Thomas H. Kee Jr. (Follow on LinkedIn) Source: Stock Traders Daily Longer Term Trading Plans for CNC Buy CNC over 63.08 target 68.50 stop loss @ 62.9 Details The technical summary data tells us to buy CNC … Read more

Centene Corporation’s 2021 Third Quarter Financial Results Conference Call

ST. LOUIS, Sept. 14, 2021 /PRNewswire/ — Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2021 third quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, October 26, 2021, and host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Michael F. Neidorff, … Read more